The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Nrf2: friend or foe for chemoprevention?
Open accessAbstract
Health reflects the ability of an organism to adapt to stress. Stresses--metabolic, proteotoxic, mitotic, oxidative and DNA-damage stresses--not only contribute to the etiology of cancer and other chronic degenerative diseases but are also hallmarks of the cancer phenotype. Activation of the Kelch-like ECH-associated protein 1 (KEAP1)-NF-E2-related factor 2 (NRF2)-signaling pathway is an adaptive response to environmental and endogenous stresses and serves to render animals resistant to chemical carcinogenesis and other forms of toxicity, whilst disruption of the pathway exacerbates these outcomes. This pathway can be induced by thiol-reactive small molecules that demonstrate protective efficacy in preclinical chemoprevention models and in clinical trials. However, mutations and epigenetic modifications affecting the regulation and fate of NRF2 can lead to constitutive dominant hyperactivation of signaling that preserves rather than attenuates cancer phenotypes by providing selective resistance to stresses. This review provides a synopsis of KEAP1-NRF2 signaling, compares the impact of genetic versus pharmacologic activation and considers both the attributes and concerns of targeting the pathway in chemoprevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Self-citation(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Self-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
(2002) · PubMed · Cited by 1,190
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Self-citationDysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D. R., et al. (2003) · Nature Genetics · doi:10.1038/ng1248 · Cited by 883
Self-citationNRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 869
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., & Lozniewski, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112203099 · Cited by 795
Self-citationLee, J.-M., Calkins, M. J., Chan, K., Kan, Y. W., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211558200 · Cited by 786
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Cullinan, S. B., & Diehl, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314219200 · Cited by 744
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
Kwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 660
Self-citationKobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 638
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637
Talalay, P., De Long, M. J., & Prochaska, H. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8261 · Cited by 591
Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., & Talalay, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051632198 · Cited by 590
Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults
OSBURN, W., & KENSLER, T. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.11.006 · Cited by 549
Self-citationPhysiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., & Yamamoto, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 513
Reynolds, A. R., Hart, I. R., Watson, A. R., Welti, J. C., Silva, R. G., Robinson, S. D., Da Violante, G., Gourlaouen, M., Salih, M., Jones, M. C., et al. (2009) · Nature Medicine · doi:10.1038/nm.1941 · Cited by 490
Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., & Talalay, P. (2001) · PubMed · Cited by 476
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473
Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M., & Hirohashi, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.082 · Cited by 468
Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., & Talalay, P. (1998) · PubMed · Cited by 424
Hong, F., Freeman, M. L., & Liebler, D. C. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0502138 · Cited by 404
Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T. W., & Yamamoto, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.185 · Cited by 387
Self-citationXu, C., Huang, M.-T., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 380
The Role of Keap1 in Cellular Protective Responses
Dinkova-Kostova, A. T., Holtzclaw, W. D., & Kensler, T. W. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050217c · Cited by 376
Self-citationIncreased skin tumorigenesis in mice lacking pi class glutathione S -transferases
Henderson, C. J., Smith, A. G., Ure, J., Brown, K., Bacon, E. J., & Wolf, C. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5275 · Cited by 376
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 370
Singh, A., Boldin-Adamsky, S., Thimmulappa, R. K., Rath, S. K., Ashush, H., Coulter, J., Blackford, A., Goodman, S. N., Bunz, F., Watson, W. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1401 · Cited by 367
NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis
Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G. H., Agoston, E. S., Yamamoto, M., & Kensler, T. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00915-07 · Cited by 348
Self-citationSussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804333106 · Cited by 346
Self-citation(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/48.5.1425 · Cited by 342
Yu, R., Chen, C., Mo, Y.-Y., Hebbar, V., Owuor, E. D., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004037200 · Cited by 340
Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A. E., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M., Cho, H.-Y., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7759com · Cited by 340
Benson, A. M., Batzinger, R. P., Ou, S.-Y. L., Bueding, E., Cha, Y., & Talalay, P. (1978) · PubMed · Cited by 337
Kwak, M.-K., Itoh, K., Yamamoto, M. P., Sutter, T. R., & Kensler, T. W. (2001) · PubMed Central · Cited by 330
Self-citationShapiro, T. A., Fahey, J. W., Dinkova-Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., & Talalay, P. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_7 · Cited by 330
Specific Patterns of Electrophile Adduction Trigger Keap1 Ubiquitination and Nrf2 Activation
Hong, F., Sekhar, K. R., Freeman, M. L., & Liebler, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503346200 · Cited by 317
Kensler, T. W., Chen, J.-G., Egner, P. A., Fahey, J. W., Jacobson, L. P., Stephenson, K. K., Ye, L., Coady, J. L., Wang, J.-B., Wu, Y., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0368 · Cited by 317
Self-citationWang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.347 · Cited by 307
Self-citationIncreased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
Khor, T. O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., Yang, C. S., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0028 · Cited by 306
Kwak, M.-K., Itoh, K., Yamamoto, M., Sutter, T. R., & Kensler, T. W. (2001) · Molecular Medicine · doi:10.1007/bf03401947 · Cited by 306
Self-citationAccelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Protective Interventions to Prevent Aflatoxin-Induced Carcinogenesis in Developing Countries
Groopman, J. D., Kensler, T. W., & Wild, C. P. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090859 · Cited by 296
Self-citationYates, M. S., Tran, Q. T., Dolan, P. M., Osburn, W. O., Shin, S., McCulloch, C. C., Silkworth, J. B., Taguchi, K., Yamamoto, M., Williams, C. R., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp100 · Cited by 269
Self-citationHypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
Wang, R., An, J., Ji, F., Jiao, H., Sun, H., & Zhou, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.004 · Cited by 259
On the mechanisms of induction of cancer-protective enzymes: a unifying proposal.
Prochaska, H. J., De Long, M. J., & Talalay, P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8232 · Cited by 257
Yang, H., Magilnick, N., Lee, C., Kalmaz, D., Ou, X., Chan, J. Y., & Lu, S. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5933-5946.2005 · Cited by 250
Lee, J.-M., Hanson, J. M., Chu, W. A., & Johnson, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100734200 · Cited by 228
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
Riedl, M. A., Saxon, A., & Diaz-Sanchez, D. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.10.007 · Cited by 221
Translational strategies for cancer prevention in liver
Kensler, T. W., Qian, G.-S., Chen, J.-G., & Groopman, J. D. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1076 · Cited by 213
Self-citationA mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Transduction of Redox Signaling by Electrophile-Protein Reactions
Rudolph, T. K., & Freeman, B. A. (2009) · Science Signaling · doi:10.1126/scisignal.290re7 · Cited by 202
Ramos-Gomez, M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.461 · Cited by 200
Benson, A. M., Cha, Y. N., Bueding, E., Heine, H. S., & Talalay, P. (1979) · PubMed · Cited by 199
Osburn, W. O., Karim, B., Dolan, P. M., Liu, G., Yamamoto, M., Huso, D. L., & Kensler, T. W. (2007) · International Journal of Cancer · doi:10.1002/ijc.22943 · Cited by 197
Self-citationStudies on the mechanism of skin tumor promotion.
Hennings, H., & Boutwell, R. K. (1970) · PubMed · Cited by 187
What is health? The ability to adapt
Lancet, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60456-6 · Cited by 179
Kim, S. K., Yang, J. W., Kim, M. R., Roh, S. H., Kim, H. G., Lee, K. Y., Jeong, H. G., & Kang, K. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.011 · Cited by 170
Nair, S., Doh, S. T., Chan, J. Y., Kong, A.-N., & Cai, L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604703 · Cited by 167
Dinkova-Kostova, A. T., Fahey, J. W., Wade, K. L., Jenkins, S. N., Shapiro, T. A., Fuchs, E. J., Kerns, M. L., & Talalay, P. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0934 · Cited by 162
Osburn, W. O., Yates, M. S., Dolan, P. D., Chen, S., Liby, K. T., Sporn, M. B., Taguchi, K., Yamamoto, M., & Kensler, T. W. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn079 · Cited by 158
Self-citationThe “Prochaska” Microtiter Plate Bioassay for Inducers of NQO1
Fahey, J. W., Dinkova‐Kostova, A. T., Stephenson, K. K., & Talalay, P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82014-7 · Cited by 157
Liby, K. T., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Honda, T., Gribble, G. W., Dmitrovsky, E., Sporn, T. A., & Sporn, M. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4534 · Cited by 142
The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
Groopman, J. D., & Kensler, T. W. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.1 · Cited by 140
Self-citationNew agents for cancer chemoprevention
Keiloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R. A., Doody, L. A., Malone, W. F., Hawk, E. T., & Sigman, C. C. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630703 · Cited by 137
Keller, U. A. D., Huber, M., Beyer, T. A., Kümin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D. A., Johnson, J. A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3773-3784.2006 · Cited by 131
Chemical Structures of Inducers of Nicotinamide Quinone Oxidoreductase 1 (NQO1)
Dinkova‐Kostova, A. T., Fahey, J. W., & Talalay, P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82023-8 · Cited by 125
Diet, metabolic polymorphisms and dna adducts: The epic‐Italy cross‐sectional study
Palli, D., Vineis, P., Russo, A. G., Berrino, F., Krogh, V., Masala, G., Munnia, A., Panico, S., Taioli, E., Tumino, R., et al. (2000) · International Journal of Cancer · Cited by 114
Primiano, T., Egner, P. A., Sutter, T. R., Kelloff, G. J., Roebuck, B. D., & Kensler, T. W. (1995) · PubMed · Cited by 105
Self-citationSpencer, S. R., Wilczak, C. A., & Talalay, P. (1990) · PubMed · Cited by 102
Prospective Type 1 and Type 2 Disulfides of Keap1 Protein
Holland, R., Hawkins, A., Eggler, A. L., Mesecar, A. D., Fabris, D., & Fishbein, J. C. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800226m · Cited by 97
Aoki, Y., Hashimoto, A. S., Amanuma, K., Matsumoto, M., Hiyoshi, K., Takano, H., Masumura, K., Itoh, K., Nohmi, T., & Yamamoto, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3355 · Cited by 84
O'Dwyer, P. J., Szarka, C. E., Yao, K.-S., Halbherr, T., Pfeiffer, G. R., Green, F., Gallo, J. M., Brennan, J., Frucht, H., Goosenberg, E. B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118904 · Cited by 83
Oltipraz: Clinical opportunities for cancer chemoprevention
Kensler, T. W., & Helzlsouer, K. J. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590813 · Cited by 82
Self-citationGasper, A. V., Τράκα, Μ., Bacon, J. R., Smith, J. A., Taylor, M. A., Hawkey, C. J., Barrett, D. A., & Mithen, R. F. (2007) · Journal of Nutrition · doi:10.1093/jn/137.7.1718 · Cited by 67
Cancer Biology and Therapeutics
(1987) · Springer eBooks · doi:10.1007/978-1-4757-9564-6 · Cited by 65
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
Gupta, E., Olopade, O. I., Ratain, M. J., et al. (1995) · PubMed · Cited by 64
Molecular Mechanisms in Protection Against Carcinogenesis
Talalay, P., Long, M. J., & Prochaska, H. J. (1987) · Springer eBooks · doi:10.1007/978-1-4757-9564-6_14 · Cited by 52
Safety and Efficacy of Weekly Oral Oltipraz in Chronic Smokers
Kelley, M. J., Glaser, E. M., Herndon, J. E., Becker, F. O., Bhagat, R., Zhang, Y., Santella, R. M., Carmella, S. G., Hecht, S. S., Gallot, L., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0585 · Cited by 40
Selecting targets for cancer prevention: where do we go from here?
Szabo, E. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2008 · Cited by 36
Nrf2 gene promoter polymorphism and gastric carcinogenesis.
Arisawa, T., Tahara, T., Shibata, T., Nagasaka, M., Nakamura, M., Kamiya, Y., Fujita, H., Yoshioka, D., Okubo, M., Hirata, I., et al. (2008) · PubMed · Cited by 31
Holland, R., Navamal, M., Velayutham, M., Zweier, J. L., Kensler, T. W., & Fishbein, J. C. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900110n · Cited by 30
Self-citationEffects of oltipraz and related chemoprevention compounds on gene expression in rat liver
Anderson, L., Steele, V. K., Kelloff, G. J., & Sharma, S. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590814 · Cited by 25
Jia, Z., Zhu, H., Trush, M. A., Misra, H. P., & Li, Y. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9598-z · Cited by 24
Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
Flora, S. D., Balansky, R. M., Scatolini, L., Marco, C. D., Gasparini, L., Orlando, M., & Izzotti, A. (1996) · PubMed · Cited by 22
Arisawa, T., Tahara, T., Shibata, T., Nagasaka, M., Nakamura, M., Kamiya, Y., Fujita, H., Yoshioka, D., Arima, Y., Okubo, M., et al. (2008) · Oncology Reports · doi:10.3892/or.19.1.211 · Cited by 21
Bae, S. K., Lee, S. J., Kim, T., Kim, J. W., Lee, I., Kim, S. G., & Lee, M. G. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20597 · Cited by 15
Anticarcinogenic and Other Protective Effects of Dithiolthiones
Bueding, E., Ansher, S. S., & Dolan, P. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5182-5_42 · Cited by 15
Cited by
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Self-citationTherapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Self-citationThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Metadata
- Authors
- Kensler, T. W., & Wakabayashi, N.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-30
- Volume
- 31
- Issue
- 1
- Pages
- 90-99
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2122116064
- Cited by
- 484
- References
- 107
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.